title: Vitamin D in HIV-Infected Patients.
abstract: Observational studies have noted very high rates of low 25(OH)D (vitamin D) levels in both the general and HIV-infected populations. In HIV-infected patients, low 25(OH)D levels are likely a combination of both traditional risk factors and HIV-specific and antiretroviral therapy-specific contributors. Because of this unique risk profile, HIV-infected persons may be at greater risk for low 25(OH)D levels and frank deficiency and/or may respond to standard repletion regimens differently than HIV-uninfected patients. Currently, the optimal repletion and maintenance dosing regimens for HIV-infected patients remain unknown, as do potential benefits of supplementation that may be unique to the HIV-infected population. This paper reviews data published on HIV infection and vitamin D health in adults over the last year.
authors.affiliation: Center for Clinical AIDS Research and Education, David Geffen School of Medicine at UCLA, USA. jlake@mednet.ucla.edu
authors.forename: Jordan E
authors.initials: JE
authors.lastname: Lake
authors.forename: John S
authors.initials: JS
authors.lastname: Adams
mesh_terms: D000328:Adult; D019587:Dietary Supplements; D006678:HIV; D015658:HIV Infections / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D014807:Vitamin D / Q000008:administration & dosage* / Q000097:blood / Q000378:metabolism*; D014808:Vitamin D Deficiency / Q000097:blood / Q000188:drug therapy / Q000378:metabolism / Q000821:virology*
chemical_list: D014807:Vitamin D